SANKYO C22 (Benicar HCT 12.5 mg / 20 mg)
Generic Name: hydrochlorothiazide/olmesartan
Pill imprint SANKYO C22 has been identified as Benicar HCT 12.5 mg / 20 mg.
Benicar HCT is used in the treatment of high blood pressure and belongs to the drug class angiotensin II inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Benicar HCT 12.5 mg / 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- SANKYO C22
- 12.5 mg / 20 mg
- 9.00 mm
- Prescription only
- Drug Class:
- Angiotensin II inhibitors with thiazides
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Sankyo Pharma
- National Drug Code (NDC):
- Inactive Ingredients:
- hydroxypropyl cellulose
low substituted hydroxypropyl cellulose
ferric oxide red
ferric oxide yellow
|NDC Code||Manufacturer / Repackager|
|54868-5170||Physicians Total Care Inc (repackager)|
|35356-0256||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about Benicar HCT (hydrochlorothiazide / olmesartan)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.